$280 Million is the total value of ARMISTICE CAPITAL, LLC's 33 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 87.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | SPDR S&P 500 ETF TRput | $40,774,000 | +112.8% | 200,000 | +100.0% | 14.55% | +122.4% | |
| ATRS | Buy | ANTARES PHARMA INC | $16,020,000 | +13.5% | 13,240,000 | +59.5% | 5.72% | +18.6% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $15,175,000 | +77.0% | 1,630,000 | +114.5% | 5.42% | +84.9% |
| FRPT | Buy | FRESHPET INC | $14,382,000 | +22.3% | 1,694,000 | +51.2% | 5.13% | +27.8% |
| RXDX | Buy | IGNYTA INC | $12,757,000 | +55.6% | 952,000 | +1.9% | 4.55% | +62.5% |
| BDSI | Buy | BIODELIVERY SCIENCES | $12,550,000 | +52.5% | 2,620,000 | +77.0% | 4.48% | +59.4% |
| THRX | Sell | THERAVANCE BIOPHARMA INC | $12,293,000 | -16.5% | 750,000 | -44.1% | 4.39% | -12.8% |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $12,140,000 | – | 1,202,000 | +100.0% | 4.33% | – |
| ENR | New | ENERGIZER HLDGS INC NEW | $10,218,000 | – | 300,000 | +100.0% | 3.65% | – |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $9,412,000 | -15.1% | 220,000 | -47.4% | 3.36% | -11.2% |
| HWAY | Buy | HEALTHWAYS INC | $9,266,000 | +18.7% | 720,000 | +2.6% | 3.31% | +24.0% |
| JCPNQ | Buy | J.C. PENNEY CO INC | $9,058,000 | +31.8% | 1,360,000 | +83.8% | 3.23% | +37.6% |
| HAIN | New | HAIN CELESTIAL GROUP INC | $9,047,000 | – | 224,000 | +100.0% | 3.23% | – |
| SPNC | Sell | SPECTRANETICS CORP | $8,825,000 | +20.0% | 586,000 | -6.1% | 3.15% | +25.4% |
| BCOR | Buy | BLUCORA INC | $8,173,000 | -23.9% | 834,000 | +6.9% | 2.92% | -20.5% |
| FL | New | FOOT LOCKER INC | $8,071,000 | – | 124,000 | +100.0% | 2.88% | – |
| DECK | Buy | DECKERS OUTDOOR CORP | $7,741,000 | +11.1% | 164,000 | +36.7% | 2.76% | +16.1% |
| THC | New | TENET HEALTHCARE CORP | $7,636,000 | – | 252,000 | +100.0% | 2.72% | – |
| EXEL | New | EXELIXIS INC | $7,163,000 | – | 1,270,000 | +100.0% | 2.56% | – |
| DMD | Buy | DEMAND MEDIA INC | $6,358,000 | +39.4% | 1,156,000 | +5.7% | 2.27% | +45.6% |
| KATE | New | KATE SPADE & CO | $6,042,000 | – | 340,000 | +100.0% | 2.16% | – |
| XNPT | Sell | XENOPORT INC | $5,929,000 | -48.7% | 1,080,000 | -67.6% | 2.12% | -46.4% |
| VSTO | New | VISTA OUTDOOR INC | $4,718,000 | – | 106,000 | +100.0% | 1.68% | – |
| New | SEAWORLD ENTMT INC | $4,608,000 | – | 234,000 | +100.0% | 1.64% | – | |
| GNCIQ | New | GNC HLDGS INC | $3,784,000 | – | 122,000 | +100.0% | 1.35% | – |
| ARCO | Sell | ARCOS DORADOS HOLDINGS INC | $3,670,000 | -3.6% | 1,180,000 | -15.7% | 1.31% | +0.8% |
| TENX | Buy | TENAX THERAPEUTICS INC | $3,247,000 | +1120.7% | 990,000 | +1015.6% | 1.16% | +1173.6% |
| TUMI | New | TUMI HLDGS INC | $3,126,000 | – | 188,000 | +100.0% | 1.12% | – |
| IILG | New | INTERVAL LEISURE GROUP INC | $2,654,000 | – | 170,000 | +100.0% | 0.95% | – |
| BKS | New | BARNES & NOBLE INC | $1,742,000 | – | 200,000 | +100.0% | 0.62% | – |
| MDGS | Buy | MEDIGUS LTDsponsored adr | $1,635,000 | -39.4% | 609,900 | +1.4% | 0.58% | -36.7% |
| RLOC | Buy | REACHLOCAL INC | $1,515,000 | +136.3% | 918,000 | +202.0% | 0.54% | +147.0% |
| New | PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $514,000 | – | 2,000,000 | +100.0% | 0.18% | – | |
| APHB | Exit | AMPLIPHI BIOSCIENCES CORP | $0 | – | -93,850 | -100.0% | -0.13% | – |
| NSPR | Exit | INSPIREMD INC | $0 | – | -6,500,000 | -100.0% | -0.37% | – |
| CPHRF | Exit | CIPHER PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.38% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -836,000 | -100.0% | -0.55% | – |
| OSTK | Exit | OVERSTOCK COM INC DEL | $0 | – | -180,000 | -100.0% | -1.06% | – |
| SNTA | Exit | SYNTA PHARMACEUTICALS CORP | $0 | – | -2,000,000 | -100.0% | -1.19% | – |
| SKUL | Exit | SKULLCANDY INC | $0 | – | -854,000 | -100.0% | -1.61% | – |
| ANF | Exit | ABERCROMBIE & FITCH COcl a | $0 | – | -240,000 | -100.0% | -1.74% | – |
| VNCE | Exit | VINCE HOLDING CORP | $0 | – | -1,540,000 | -100.0% | -1.80% | – |
| FTDCQ | Exit | FTD COS INC | $0 | – | -186,000 | -100.0% | -1.89% | – |
| DFRG | Exit | DEL FRISCOS RESTAURANT GROUP | $0 | – | -422,000 | -100.0% | -2.00% | – |
| LVS | Exit | LAS VEGAS SANDS CORP | $0 | – | -190,000 | -100.0% | -2.46% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -506,000 | -100.0% | -2.66% | – |
| GMCR | Exit | KEURIG GREEN MTN INC | $0 | – | -154,000 | -100.0% | -2.74% | – |
| APOL | Exit | APOLLO ED GROUP INCcl a | $0 | – | -880,000 | -100.0% | -3.32% | – |
| PBY | Exit | PEP BOYS MANNY MOE & JACK | $0 | – | -840,000 | -100.0% | -3.50% | – |
| BDBD | Exit | BOULDER BRANDS INC | $0 | – | -1,266,000 | -100.0% | -3.54% | – |
| KODK | Exit | EASTMAN KODAK CO | $0 | – | -804,000 | -100.0% | -4.29% | – |
| PTX | Exit | PERNIX THERAPEUTICS HOLDINGS | $0 | – | -4,800,000 | -100.0% | -5.18% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCcall | $0 | – | -400,000 | -100.0% | -5.25% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Armistice Capital Master Fund Ltd. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.